TherapeuticsMD (TXMD) Cost of Revenue (2011 - 2023)
TherapeuticsMD's (TXMD) quarterly Cost of Revenue came in at -$33000.0 in Q4 2023, down 131.13% on a QoQ basis from $106000.0 in Q3 2023.
TherapeuticsMD (TXMD) Cost of Revenue (2011 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 13 years of Cost of Revenue data on file, last reported at -$33000.0 in Q4 2023.
- Quarterly Cost of Revenue changed N/A year-over-year to -$33000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $73000.0 (down 94.77% YoY) and the FY2022 annual result came in at $1.4 million, changed 0.36% from the prior year.
- Cost of Revenue slipped to -$33000.0 in Q4 2023, from $106000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $5.6 million in Q4 2020 to a low of -$12.7 million in Q4 2021.
- A 5-year average of $1.5 million and a median of $1.4 million in 2019 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2020 — Cost of Revenue soared 255.91% — and 2021, when it sank 327.54%.
- Tracing TXMD's Cost of Revenue over 5 years: stood at $2.9 million in 2019, then soared by 93.85% to $5.6 million in 2020, then slumped by 327.54% to -$12.7 million in 2021, then surged by 102.79% to $354000.0 in 2022, then tumbled by 109.32% to -$33000.0 in 2023.
- The last three Cost of Revenue figures came in at -$33000.0 (Q4 2023), $106000.0 (Q3 2023), and $354000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -33,000.00 |
| Dec 31, 2023 | -33,000.00 |
| Sep 30, 2023 | 106,000.00 |
| Sep 30, 2023 | 106,000.00 |
| Sep 30, 2022 | 354,000.00 |
| Sep 30, 2022 | 354,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Mar 31, 2022 | 695,000.00 |
| Mar 31, 2022 | 695,000.00 |
| Dec 31, 2021 | -12.70 Mn |
| Dec 31, 2021 | -12.70 Mn |
| Sep 30, 2021 | 5.28 Mn |
| Sep 30, 2021 | 5.28 Mn |
| Jun 30, 2021 | 4.13 Mn |
| Jun 30, 2021 | 4.13 Mn |
| Mar 31, 2021 | 4.69 Mn |
| Mar 31, 2021 | 4.69 Mn |
| Dec 31, 2020 | 5.58 Mn |
| Dec 31, 2020 | 5.58 Mn |